AUSTIN, TX and PLYMOUTH, MN (May 24, 2016) – Entellus Medical, Inc. (NASDAQ: ENTL) and Fiagon NA Corporation announced today that they have expanded their agreement allowing Entellus to exclusively distribute Fiagon branded Navigation Systems and accessories in the United States and Canada.

Hennigsdorf – For the 23rd time, the TOP 100 are distinguished as the most innovative of Germany’s medium-sized companies. Fiagon AG is especially celebrating – in its size class (companies with up to 50 employees), it placed above all the others.

Berlin / Bonn, 31. Mai 2016 – Die Fiagon GmbH eröffnet in Bonn gemeinsam mit der Beta Klinik GmbH ein Referenzzentrum für navigierte Neurochirurgie.

Berlin, GERMANY (March 2016) – Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration (FDA) 510k clearance for its brain navigation software.

Berlin, GERMANY (March 22, 2016) – Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration (FDA) clearance for new ENT instruments.

Berlin (March 17, 2016) – Fiagon AG, a manufacturer of clinical navigation systems, today announced it has increased its investment budget by 7.5 million euros with the support of Donghai Securities (Donghai), one of China’s most successful investment banks, and the German Startups Group, an investment company headquartered in Berlin and focusing on young, rapidly growing businesses.